Detalhe da pesquisa
1.
Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1-2 study.
Lancet
; 402(10402): 641-654, 2023 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37295445
2.
Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study.
Lancet Oncol
; 23(8): 1066-1077, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35839786
3.
Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT Study.
Clin Infect Dis
; 71(9): 2365-2374, 2020 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32076709
4.
Elderly do benefit from induction chemotherapy: High dose mitoxantrone-based ("5 + 1") induction chemotherapy regimen in newly diagnosed acute myeloid leukemia.
Am J Hematol
; 94(2): 209-215, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30417942
5.
Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma.
Biol Blood Marrow Transplant
; 23(2): 269-277, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27864161
6.
Mitoxantrone-Induced Cardiotoxicity in Acute Myeloid Leukemia-A Velocity Vector Imaging Analysis.
Echocardiography
; 33(8): 1166-77, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27109429
7.
A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation.
Biol Blood Marrow Transplant
; 21(12): 2100-2105, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26327631
8.
Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 21(7): 1155-66, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25769794
9.
Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma.
Biol Blood Marrow Transplant
; 20(7): 951-9, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24641828
10.
Safety and efficacy of autologous hemopoietic progenitor cell collection in tandem with hemodialysis in multiple myeloma with myeloma cast nephropathy.
J Clin Apher
; 29(2): 83-9, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23959911
11.
Results from a Phase 1 Study of ACTR707 in Combination with Rituximab in Patients with Relapsed or Refractory CD20+ B Cell Lymphoma.
Transplant Cell Ther
; 30(2): 241.e1-241.e8, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37898374
12.
PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study.
Oral Oncol
; 149: 106634, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38118249
13.
Salvage second hematopoietic cell transplantation in myeloma.
Biol Blood Marrow Transplant
; 19(5): 760-6, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23298856
14.
Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis.
Blood
; 118(7): 1979-88, 2011 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-21690560
15.
Myeloid/lymphoid neoplasm with ZMYM2::FGFR1 rearrangement: A complex trilineage phenotypic and clonal evolution with associated genomic alterations.
Leuk Res Rep
; 19: 100370, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37275466
16.
Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant.
Open Forum Infect Dis
; 10(8): ofad386, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37636519
17.
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results.
Nat Med
; 29(2): 422-429, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36690811
18.
Calcineurin inhibitor-free GVHD prophylaxis with sirolimus and mycophenolate mofetil combination.
Ann Hematol
; 96(9): 1563-1568, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28710649
19.
Evaluation of the abuse potential of extended release hydromorphone versus immediate release hydromorphone.
J Clin Psychopharmacol
; 30(1): 25-33, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20075644
20.
First-in-Human Phase I Study of ABBV-838, an Antibody-Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma.
Clin Cancer Res
; 26(10): 2308-2317, 2020 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31969330